- Health Conditions
- Events
- Ask a Doctor
- Visit A Doctor
- HCP Portal
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
Browsing: Duke-nus
As global populations continue to age, the pursuit of effective anti-ageing treatments has never been more urgent. Recent findings from…
Log In or Register as a healthcare professional to read the full article.
This research exemplifies Duke-NUS’s collaborative spirit, combining expertise across disciplines to push the boundaries of medical science. Professor Patrick Tan, Senior Vice-Dean for Research at Duke-NUS, said: “This is a sterling example of how different research programmes within the School come together to tap their various expertise to advance medical knowledge and improve patients’ lives. The team’s valuable insights may one day translate into a new treatment option to control tumour growth or even offer a cure for cancer.”
The Duke-NUS research team, collaborating with Duke University and the National University of Singapore, conducted a preclinical comparison between nasal and subcutaneous administration of the COVID-19 vaccine. Their findings were published in eBioMedicine. It revealed that the intranasal route not only induces a strong mucosal antibody response but also enhances long-term mucosal and systemic immune protection.
Subscribe to Updates
Subscribe to receive latest health related news from us
The contents on Medical Channel Asia are for general educational purposes only.
It is not intended to be a substitute for professional medical advice, treatment, or diagnosis.
See additional information.